Outcomes of Left Ventricular Assist Device Implantation as Destination Therapy in the Post-REMATCH Era | Zendy

Katherine Lietz | Zendy; James W. Long | Zendy; Abdallah G. Kfoury | Zendy; Mark S. Slaughter | Zendy; Marc A. Silver | Zendy; Carmelo A. Milano | Zendy; Joseph G. Rogers | Zendy; Yoshifumi Naka | Zendy; Donna Mancini | Zendy; Leslie W. Miller | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Outcomes of Left Ventricular Assist Device Implantation as Destination Therapy in the Post-REMATCH Era

Author(s) -

Katherine Lietz,

James W. Long,

Abdallah G. Kfoury,

Mark S. Slaughter,

Marc A. Silver,

Carmelo A. Milano,

Joseph G. Rogers,

Yoshifumi Naka,

Donna Mancini,

Leslie W. Miller

Publication year - 2007

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.107.691972

Subject(s) - medicine , heart failure , ventricular assist device , destination therapy , heart transplantation , inotrope , cardiology , transplantation , surgery

The landmark Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) trial first demonstrated that implantation of left ventricular assist devices (LVADs) as destination therapy (DT) can provide survival superior to any known medical treatment in patients with end-stage heart failure who are ineligible for transplantation. In the present study, we describe outcomes of DT in the post-REMATCH era in the United States.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research